stockrowImmuCell Corporation (ICCC) vs Seer, Inc. (SEER)
- ImmuCell Corporation ICCC 9.88 −4.73%
- Seer, Inc. SEER 1.64 −3.53%
ImmuCell Corporation and Seer, Inc. are both Biotechnology companies. ImmuCell Corporation and Seer, Inc. are of similar size ($94.2M and $94.1M). Seer, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 117×. ImmuCell Corporation grew revenue faster over the last twelve months: 8.49% against −12.7%. ImmuCell Corporation has the higher net margin (2.57% vs −478.1%) and the higher return on invested capital (7.84% vs −60.8%). Across the 19 metrics below, ImmuCell Corporation leads on 12 and Seer, Inc. on 7.
Valuation
Profitability
| Metric | ICCC | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 40.32% | 47.70% | 65.16% |
| Operating margin | 12.60% | (498.19%) | 0.00% |
| Net margin | 2.57% | (478.05%) | 0.00% |
| Free cash flow margin | 13.79% | (309.34%) | 0.00% |
| Return on equity | 2.57% | (26.45%) | (50.12%) |
| Return on assets | 1.69% | (23.47%) | (45.60%) |
| Return on invested capital | 7.84% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack